Clinical Trial Update: Sintilimab in Combination With S-1/Oxaliplatin With Nab-paclitaxel Intraperitoneal Infusion for Untreated Advanced Gastric Cancer With Malignant Ascites [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating sintilimab with S-1/oxaliplatin plus nab-paclitaxel intraperitoneal infusion for untreated advanced gastric cancer with malignant ascit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ascites Malignant
• Gastric Cancer
• Peritoneal Metastases

Drugs mentioned

• Sintilimab (sintilimab)

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Gastric Cancer, Peritoneal Metastases | Phase 2 | Status: UNKNOWN